PRENW — Prenetics Global Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1876431 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 46,488,000 | 30,203,000 | -21,919,000 | -8,983,000 | 153,655,000 | 59,050,000 | 60,732,000 |
| Mar 2026 | 35,954,000 | 23,283,000 | -9,706,000 | -23,104,000 | 175,302,000 | 56,017,000 | 54,280,000 |
| Dec 2025 | 36,558,000 | 21,588,000 | -13,136,000 | -7,501,000 | 206,073,000 | 32,131,000 | 49,707,000 |
| Sep 2025 | 23,555,000 | 14,024,000 | -6,559,000 | -7,408,000 | 196,507,000 | 13,264,000 | 35,305,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-37,175,000
Investing CF
$71,870,000
Financing CF
$-37,477,000
CapEx
—
Dividends Paid
$0
Buybacks
$-40,037,000
EPS Diluted TTM
—
As of
2026-09-11
Balance + Analyst (yfinance extras)
Retained Earnings
$-554,781,000
Inventory
$13,991,000
Receivables
$24,296,000
ST Investments
$50,342,000
EBIT TTM
$-47,962,000
Pretax Income TTM
$-52,828,000
Interest Exp TTM
$234,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$154,592,992
EBITDA
$-53,972,000
Free Cash Flow
$-36,145,376
Enterprise Value
—
Total Cash
$128,557,000
Total Debt
$682,000
Shares Out
—
Trailing EPS
$-11.04
Book Value
$5.39
ROE
-47.0%
ROA
-18.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 92,390,000 | -38,129,000 | -37,709,000 | 206,073,000 | 49,707,000 | 156,459,000 | -21,826,000 |
| Dec 2024 | 15,936,000 | -38,277,000 | -46,304,000 | 213,575,000 | 42,229,000 | 170,389,000 | -28,874,000 |
| Dec 2023 | 6,155,000 | -42,469,000 | -62,724,000 | 254,171,000 | 44,013,000 | 206,359,000 | -13,765,000 |
| Dec 2022 | 13,164,000 | -65,917,000 | -190,454,000 | 312,131,231 | 68,668,371 | 237,064,127 | 14,515,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.26T | $1415.55 | — |
| JNJ | JOHNSON & JOHNSON | $670.92B | $278.70 | — |
| ABBV | AbbVie Inc. | $517.59B | $292.82 | — |
| MRK | Merck & Co., Inc. | $353.44B | $143.37 | — |
| NVS | NOVARTIS AG | $302.46B | $159.13 | — |
News headlines (Yahoo Finance, 1h cache)
Prenetics Global Limited Q3 2026 Earnings Call Summary
2026-11-18 22:11 · Yahoo
What Prenetics Global (PRE) Said on Its Q3 Earnings Call
2026-11-18 18:14 · Yahoo
Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230
2026-11-18 13:01 · Yahoo
PRE: Hitting All the Right Notes
2026-11-18 12:49 · Yahoo
Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
2026-11-16 13:30 · Yahoo
Care Bears And Prenetics' IM8 Announce Global Partnership
2026-11-05 13:32 · Yahoo
Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
2026-11-05 13:30 · Yahoo
PRE Announces Strategic Partnership
2026-11-05 11:00 · Yahoo
Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
2026-11-03 14:05 · Yahoo
IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
2026-10-12 13:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.